You are here: Industry Insights > COVID-19 vaccine

News List

European Commission buys additional doses of Moderna’s Covid-19 vaccine pharmaceutical-business-review
June 23, 2021
The European Commission has purchased an additional 150 million Moderna’s Covid-19 vaccine doses, bringing its confirmed order commitment to 460 million doses.
EU gets partial win in AstraZeneca Covid-19 vaccine supply case pharmaceutical-technology
June 23, 2021
The Court of First Instance in Brussels, Belgium, has ordered AstraZeneca to supply 80.2 million doses of its Covid-19 vaccine by 27 September, representing only a partial win for the EU.
CureVac provides update on Phase 2b/3 trial of first-generation COVID-19 vaccine candidate, CVnCoV worldpharmanews
June 21, 2021
CureVac N.V., a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), announced results of the second interim analysis of its international pivotal Phase 2b/3 study in ...
AstraZeneca welcomes Court ruling on supply of its COVID-19 vaccine to Europe worldpharmanews
June 21, 2021
AstraZeneca welcomed the ruling by the Court of First Instance in Brussels. The European Commission had requested 120 million vaccine doses cumulatively by the end of June 2021, and a total of 300 million doses by the end of September 2021.
CureVac’s COVID-19 vaccine misses the mark in late-stage study pharmatimes
June 18, 2021
German biopharma company CureVac has announced that its COVID-19 vaccine candidate CVnCoV missed the prespecified statistical success criteria in a Phase II/III study.
Australia recommends AstraZeneca Covid-19 vaccine for people over 60 pharmaceutical-technology
June 18, 2021
The Australian Technical Advisory Group on Immunisation (ATAGI) has recommended the use of the AstraZeneca Covid-19 vaccine in Australia for individuals aged above 60 years.
U.S. government purchases additional 200 million doses of Moderna's COVID-19 vaccine worldpharmanews
June 17, 2021
Moderna announced that the U.S. government has purchased an additional 200 million doses of Moderna's COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates from Moderna's pipeline.
G7 to share 870 million doses of COVID-19 vaccine with poorest countries europeanpharmaceuticalreview
June 17, 2021
Global leaders at the G7 summit pledged 870 million COVID-19 vaccine doses, with half to be delivered by the end of 2021, to COVAX for distribution among low- and middle-income countries.
Influenza Vaccine and Novavax COVID-19 Vaccine Simultaneous Administration Yields Positive Results americanpharmaceuticalreview
June 17, 2021
Novavax Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced data from the first co-administration study of a SARS-CoV-2 vaccine candidate [Novavax, NVX-CoV2373] and an approved influenza vaccine ...
Janssen COVID-19 Vaccine – one regulator blocks use, another promotes it europeanpharmaceuticalreview
June 16, 2021
EU recommends that batches of Janssen COVID-19 Vaccine not be released for use due to a cross contamination report, while the FDA authorises use of drug substance from the facility where the contamination occurred.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page